Tissue Regenix Group plc: US Regional Distribution Agreement Signed
[PR Newswire] – Tissue Regenix Group plc (TRX.L) (“Tissue Regenix” or “the Group”), the regenerative medical devices company, announces that TRX Wound Care Inc. has signed a new regional distribution contract for DermaPure® which is used in the treatment of chronic and acute wounds. There has been substantial commercial interest in Dermapure® since Tissue Regenix received notice of Local Coverage Determination (LCD) from Novitas, as announced on 5 March 2015